Search

everythinglearnresearchcommunity

for

Search:↓

Doctors need to be better prepared to assess and treat obesity in patients.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

DHT, a testosterone byproduct, causes male pattern baldness.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Steroidogenic isoenzymes may help improve treatments for common hair loss.